After three years and three different commissioners, one of the Food and Drug Administration's most contentious issues finally has been resolved. Plan B, the so-called "morning-after" contraceptive pill, will be sold over the counter to women 18 and older. Gardiner Harris is public health reporter for the New York Times.
KCRW
